Key result
Thrombolytic therapy remains linked to reduced infarct size despite abnormal Q waves on admission ECG.
Why the study?
Severe myocardial ischemia can produce early QRS changes without infarction, making baseline abnormal Q waves potentially inaccurate markers of irreversibly injured myocardium.
Does the presence of abnormal Q waves on the admission ECG reduce the efficacy of thrombolytic therapy in reducing infarct size in patients with acute myocardial infarction?
Cohort (n=695)
Yes
Does the presence of abnormal Q waves on the admission ECG reduce the efficacy of thrombolytic therapy in reducing infarct size in patients with acute myocardial infarction?
p-value: p=<0.0001
The presence of abnormal Q waves early in the course of acute myocardial infarction does not preclude a beneficial reduction in infarct size from thrombolytic therapy.
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Raitt et al. found in a subgroup of 432 first MI patients whose ECG was recorded within the first hour after onset of chest pain that pathologic Q-waves were already present, and this was particularly true for anterior MI patients. These patients had larger final infarct size, but equal benefit from thrombolytic therapy.”
“We've found that often if the delay is longer than three hours and you are able to take the person to the catheterisation laboratory and do angioplasty that is the best thing to do.”
“Whereas it has been argued that baseline Q-waves are 'a poor predictor of symptom duration,' our data support prior observations from fibrinolytic-treated patients contending that they are independent from time from symptom onset and likely represent a more accurate reflection of the wave front of myocardial necrosis.”
Abnormal Q waves should not preclude thrombolysis consideration; this Level 3 cohort finding leaves open need for randomized confirmation.
Raitt et al. (1995) conducted a cohort in Acute myocardial infarction (n=695). Thrombolytic therapy was evaluated on Final infarct size (p=<0.0001). Abnormal Q waves on admission ECG did not eliminate the beneficial effect of thrombolytic therapy on reducing final infarct size (p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: